While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...

A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance ...

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...

The PDCO’s positive opinion is based on PolTREG’s original preTreg clinical trial protocol initiated in October 2024, which enrolled children aged 6–16 years in Stage 1 type 1 diabetes. In its ...

Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...

The decision was taken following a plenary meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) on May 5, 2025 and is based on reports of 17 SAEs worldwide (including two deaths) in ...

Few areas of healthcare are as sensitive as cancer treatment. Each year, around 44,000 cancer tumours are diagnosed here.

A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines ...

Morningstar brands and products Company Portfolio ...